Rapport Therapeutics, Inc. RAPP Operating Lease Liabilities
Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Rapport Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.
The official record: Rapport Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rapport Therapeutics, Inc.'s operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rapport Therapeutics, Inc.'s operating lease liabilities?
- Rapport Therapeutics, Inc. (RAPP) reported operating lease liabilities of $8.19M in Q1 2026.
- How has Rapport Therapeutics, Inc.'s operating lease liabilities changed year-over-year?
- Rapport Therapeutics, Inc.'s operating lease liabilities increased by 19.8% year-over-year, from $6.83M to $8.19M.
- What is the long-term trend for Rapport Therapeutics, Inc.'s operating lease liabilities?
- Over 2 years (2023 to 2025), Rapport Therapeutics, Inc.'s operating lease liabilities has grown at a 143.2% compound annual growth rate (CAGR), from $1.48M to $8.73M.
- What does operating lease liabilities mean?
- Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.